JP MORGAN/CALL/ELI LILLY & CO/710/0.01/20.09.24 Stock

Warrant

DE000JK2EXU4

Market Closed - Börse Stuttgart 04:44:24 2024-06-25 am EDT
1.83 EUR +2.23% Intraday chart for JP MORGAN/CALL/ELI LILLY & CO/710/0.01/20.09.24
Current month+46.40%
1 month+55.08%
Date Price Change
24-06-25 1.83 +2.23%
24-06-24 1.79 +0.56%
24-06-21 1.78 -2.73%
24-06-20 1.83 -1.08%
24-06-19 1.85 +2.78%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 04:44 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
Issuer J.P. Morgan
WKN JK2EXU
ISINDE000JK2EXU4
Date issued 2024-02-08
Strike 710 $
Maturity 2024-09-20 (86 Days)
Parity 100 : 1
Emission price 0.68
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.86
Lowest since issue 0.7
Delta0.99x
Omega 4.412
Premium0.9x
Gearing4.48x
Moneyness 1.273
Difference Strike -191.3 $
Difference Strike %-26.94%
Spread -0.09
Spread %4.89%
Intrinsic value 1.846
Present value 0.0388

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3 USD
Average target price
860.5 USD
Spread / Average Target
-4.52%
Consensus